Page last updated: 2024-10-24

celecoxib and Cyst

celecoxib has been researched along with Cyst in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Autosomal dominant polycystic kidney disease (ADPKD) is a progressive chronic kidney disease."5.38Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. ( Fu, LL; Mei, CL; Wang, NS; Xu, T; Ye, CY; Yu, SQ, 2012)
"Autosomal dominant polycystic kidney disease (ADPKD) is a progressive chronic kidney disease."1.38Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. ( Fu, LL; Mei, CL; Wang, NS; Xu, T; Ye, CY; Yu, SQ, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tellegen, AR1
Rudnik-Jansen, I1
Pouran, B1
de Visser, HM1
Weinans, HH1
Thomas, RE1
Kik, MJL1
Grinwis, GCM1
Thies, JC1
Woike, N1
Mihov, G1
Emans, PJ1
Meij, BP1
Creemers, LB1
Tryfonidou, MA1
Xu, T1
Wang, NS1
Fu, LL1
Ye, CY1
Yu, SQ1
Mei, CL1

Other Studies

2 other studies available for celecoxib and Cyst

ArticleYear
Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis.
    Drug delivery, 2018, Volume: 25, Issue:1

    Topics: Animals; Anterior Cruciate Ligament; Biocompatible Materials; Bone and Bones; Celecoxib; Cyclooxygen

2018
Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
    Molecular biology reports, 2012, Volume: 39, Issue:7

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Celecoxib; Cell Cycle Checkpoints; Cell P

2012